Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 5, 2007, Pages 480-483

  Ogilvie, Gina ^a,c   Krajden, Mel ^a   Maginley, Juanita ^a   Isaac Renton, Judy ^a   Hislop, Greg ^b   Elwood Martin, Ruth ^c   Sherlock, Chris ^d   Taylor, Darlene ^a   Rekart, Michael ^a  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Providence Health Care Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CANCER SCREENING; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NURSE; PAPANICOLAOU TEST; POPULATION; UTERINE CERVIX CANCER; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS; WOMEN'S HEALTH;

EID: 34548436877     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070013     Document Type: Article

References (21)

1. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272:530-4.
2. Snider JA, Beauvais JE. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status. Chronic Dis Can 1998;19:19-24.
3. Snider J, Beauvais J, Levy I, et al. Trends in mammography and Pap smear utilization in Canada. Chronic Dis Can 1996;17:108-17.
4. Archibald CP, Coldman A, Wong FL, et al. The incidence of cervical cancer among Chinese and Caucasians in British Columbia. Can J Public Health 1993;84:283-5.
5. Hislop TG, Deschamps M, Band PR, et al. Participation in the British Columbia Cervical Cytology Screening Programme by Native Indian women. Can J Public Health 1992; 83:344-5.
6. Band PR, Gallagher RP, Threlfall WJ, et al. Rate of death from cervical cancer among native Indian women in British Columbia. CMAJ 1992;147:1802-4.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
8. Farley M, Golding JM, Minkoff JR. Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract 2002;51:827-31.
9. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self obtained HPV cervicovaginal samples vs clinician obtained samples: a systematic review. Sex Transm Infect 2005;81:207-12.
10. Patrick DM, Rekart ML, Jolly A, et al. Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control. Sex Transm Infect 2002;78(Suppl 1):i164-9.
11. Statistics Canada. Canadian Community Health Survey (CCHS): cycle 1.1: extending the wealth of health data in Canada. Ottawa: Statistics Canada; 2003. Available: www.statcan.ca/english/concepts/health/cchsinfo.htm#cont (accessed 2007 July 26).
12. Rosner B. Fundamentals of biostatistics. 5th ed. Pacific Grove (CA): Duxbury; 2000. p. 612-25.
13. British Columbia Cancer Agency. 2005 annual report: Cervical Cancer Screening Program. Vancouver: The Agency; 2005. Available: www.bccancer.bc.ca/NR/rdonlyres/34F5A494-73CD-4A7C-908A-D34F9E7B1F09/15237/ 2005ccsp_annual_reportFINAL.pdf (accessed 2007 June 25).
14. Sajan A, Corneil T, Grzybowski S. The street value of prescription drugs. CMAJ 1998;159:139-42.
15. Moore RA FD, Moravan V, Amirabbasi-Biek M, et al. HPV type distribution in North America - a population based study of 5000 British Columbia women. 23rd International Papillomavirus Conference and Clinical Workshop; 2006 September 1-7; Prague, Czech Republic. Prague: The Institute of Hematology and Blood Transfusion; 2006. p. 295.
16. The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N Engl J Med 2007;356:1915-27.
17. Flores Y, Bishai D, Lazcano E, et al. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study. Salud Publica Mex 2003;45(Suppl 3):S388-98.
18. Ogilvie GS, Shaw EA, Lusk S, et al. Access to colposcopy for at risk Canadian women: Can we do better? Can J Public Health 2004;95:346-51.
19. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
20. Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-25.
21. Denny L, Kuhn L, De Souza M, et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005;294:2173-81.